Consolidated Statements of Cash Flows - USD ($)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Cash flows provided by (used in) operating activities
Net income (loss)	$ 3,008,790	$ (1,861,449)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Depreciation and amortization	94,456	123,680
Amortization of debt discount	267,959	16,487
Operating leases amortization	567,078	484,793
Stock based compensation expense	2,748,300	2,279,496
Changes in assets and liabilities:
Accounts receivable	(4,416,390)	(1,692,607)
Prepaid expenses and other current assets	(157,800)	(1,918,109)
Accounts payable and accrued liabilities	308,131	1,636,326
Accrued salaries and wages	(596,929)	(338,352)
Operating lease liabilities	(571,044)	(483,412)
Royalty payable	1,012,076	287,890
Deferred revenue	(338,138)	(563,516)
Net cash provided by (used in) operating activities	1,926,489	(2,028,773)
Cash flows used in investing activities
Purchase of marketable securities	(15,014,750)	0
Purchase of property and equipment	0	(50,887)
Net cash used in investing activities	(15,014,750)	(50,887)
Cash flows provided by financing activities
Proceeds from debt issuance	0	20,000,000
Debt issuance costs	0	(1,315,941)
Proceeds from exercise of options and warrants	2,718,940	685,100
Net cash provided by financing activities	2,718,940	19,369,159
Effect of foreign currency translation on cash	(28,068)	(18,636)
Net (decrease) increase  in cash and cash equivalents	(10,397,389)	17,270,863
Cash and cash equivalents, beginning of year	48,251,336	30,980,473
Cash and cash equivalents, end of year	37,853,947	48,251,336
Supplemental disclosure
Interest paid during the year	1,535,617	0
Taxes paid during the year	0	39,000
Non-Cash Investing and Financing Transactions
Cashless exercise of options	27	2
Issuance of restricted stock	20
Common stock issued for debt conversion	3,062,200	0
Debt issuance cost associated with debt conversion	162,780	0
Right of use assets obtained in exchange for new lease obligations	$ 1,189,168	$ 0